Choose A when
NAD+
For broad longevity signaling — NAD+ is the substrate for all sirtuins and PARPs. Better-studied corpus.
See full profileComparison
Both raise the cellular NAD+ pool but via different mechanisms. NAD+ is administered directly (s.c./IV) — supplementation. 5-Amino-1MQ is the first selective NNMT inhibitor — blocking nicotinamide breakdown to indirectly raise NAD+.
| Spec | A NAD+ | B 5-Amino-1MQ |
|---|---|---|
| Approach | Direct supplementation | Enzyme inhibition (NNMT) |
| Origin | Natural coenzyme | Synthetic small molecule (Cornell, 2018) |
| Type | Dinucleotide (nucleotide-based) | Small molecule (not a peptide) |
| Administration | s.c. 50-200 mg or IV 250-1000 mg | Oral 50-100 mg daily |
| Additional effect | Activates sirtuins (SIRT1-7) | Raises SAM (S-adenosylmethionine) |
| Preclinical data (fat metabolism) | Indirect, via sirtuin activation | >25% fat reduction in 11 days (mice, no diet) |
Choose A when
For broad longevity signaling — NAD+ is the substrate for all sirtuins and PARPs. Better-studied corpus.
See full profileChoose B when
For metabolic focus — NNMT inhibition directly impacts fat metabolism. Orally active, convenient.
See full profileVerdict
The two are complementary — 5-Amino-1MQ potentiates any NAD+ dose by blocking breakdown. Often stacked for maximum NAD+ elevation.
Other comparisons